2023-03-30T16:58:22+08:00 weekly 1.0 https://ee.prisysbiotech.com/ 2024-11-13T14:57:57+08:00 weekly 0.9 https://ee.prisysbiotech.com/translational-research-center 2024-11-13T14:58:10+08:00 weekly 0.9 https://ee.prisysbiotech.com/ophthalmic-disease-research 2023-03-31T23:23:20+08:00 weekly 0.9 https://ee.prisysbiotech.com/co-develop 2024-11-13T14:58:02+08:00 weekly 0.9 https://ee.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T14:57:59+08:00 weekly 0.9 https://ee.prisysbiotech.com/respiratory-disease-research 2024-11-13T14:58:01+08:00 weekly 0.9 https://ee.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T14:58:01+08:00 weekly 0.9 https://ee.prisysbiotech.com/hematological-disease-research 2024-11-13T14:58:03+08:00 weekly 0.9 https://ee.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:58:01+08:00 weekly 0.9 https://ee.prisysbiotech.com/animal-welfare 2024-11-13T14:57:56+08:00 weekly 0.9 https://ee.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://ee.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://ee.prisysbiotech.com/nephrology 2024-11-13T14:57:53+08:00 weekly 0.9 https://ee.prisysbiotech.com/about-us 2024-11-13T14:58:02+08:00 weekly 0.9 https://ee.prisysbiotech.com/contact-us 2023-03-31T23:23:15+08:00 weekly 0.9 https://ee.prisysbiotech.com/newslist-1 2024-11-13T14:57:52+08:00 weekly 0.9 https://ee.prisysbiotech.com/products 2023-03-31T23:05:14+08:00 weekly 1.0 https://ee.prisysbiotech.com/nhp-pharmacology/ 2023-03-31T23:05:14+08:00 weekly 0.9 https://ee.prisysbiotech.com/pk-pd-adme/ 2023-03-31T23:05:15+08:00 weekly 0.9 https://ee.prisysbiotech.com/translation-research/ 2023-03-31T23:05:15+08:00 weekly 0.9 https://ee.prisysbiotech.com/safety-evaluation/ 2023-03-31T23:05:15+08:00 weekly 0.9 https://ee.prisysbiotech.com/biosafety-research/ 2024-04-11T16:07:11+08:00 weekly 0.9 https://ee.prisysbiotech.com/clearpoint/ 2023-03-31T23:23:09+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-13T14:57:59+08:00 weekly 0.8 https://ee.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T14:57:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-13T15:01:20+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-31T23:23:08+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T14:57:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-13T14:57:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-13T14:57:49+08:00 weekly 0.8 https://ee.prisysbiotech.com/translation-research/nhpresources.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-13T14:58:09+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-13T14:57:57+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-31T23:23:11+08:00 weekly 0.8 https://ee.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T14:57:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-31T23:23:10+08:00 weekly 0.8 https://ee.prisysbiotech.com/translation-research/translational-studies.html 2023-03-31T23:23:10+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-31T23:23:12+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-13T14:57:53+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-31T23:23:10+08:00 weekly 0.8 https://ee.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-13T14:57:54+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-31T23:23:13+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-31T23:23:13+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-31T23:23:22+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-31T23:23:11+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-31T23:23:15+08:00 weekly 0.8 https://ee.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-31T23:23:13+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-13T14:58:00+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-13T14:58:05+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-13T14:58:05+08:00 weekly 0.8 https://ee.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-31T23:23:13+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-31T23:23:15+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-13T14:57:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-13T14:57:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-31T23:23:11+08:00 weekly 0.8 https://ee.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T14:58:00+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-13T14:57:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ee.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-13T14:58:03+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-13T14:58:00+08:00 weekly 0.8 https://ee.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T14:58:09+08:00 weekly 0.8 https://ee.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T14:57:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T14:58:26+08:00 weekly 0.8 https://ee.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-27T00:10:59+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-27T00:11:02+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-27T00:11:03+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-27T00:11:04+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-27T00:11:10+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-27T00:11:11+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-11-13T14:57:57+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-12-07T14:24:04+08:00 weekly 0.8 https://ee.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-07T19:59:08+08:00 weekly 0.8 https://ee.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-02T14:00:40+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-02T14:37:27+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-17T23:20:36+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-17T23:20:37+08:00 weekly 0.8 https://ee.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-20T08:13:39+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T05:04:41+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T06:35:26+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T01:58:04+08:00 weekly 0.8 https://ee.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-30T21:26:38+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T16:00:49+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T19:27:51+08:00 weekly 0.8 https://ee.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T23:23:05+08:00 weekly 0.9 https://ee.prisysbiotech.com/newslist-714055-1 2023-03-31T23:23:05+08:00 weekly 0.9 https://ee.prisysbiotech.com/newslist-714056-1 2024-07-30T00:33:04+08:00 weekly 0.9 https://ee.prisysbiotech.com/newslist-818801-1 2023-03-31T23:23:06+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/meetprisys-sot2023-66112673.html 2023-03-31T23:23:07+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66112674.html 2023-03-31T23:23:06+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-sot2023-66112675.html 2023-03-31T23:23:06+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66112676.html 2023-03-31T23:23:07+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66112677.html 2023-03-31T23:23:08+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/gene-therapy-nhp-model-66112678.html 2023-03-31T23:23:07+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66112679.html 2023-03-31T23:23:08+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66112680.html 2023-03-31T23:23:11+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66112681.html 2023-03-31T23:23:14+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66112682.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/gene-therapy-toxicology-66273558.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67527636.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/world-parkinsons-disease-day-67527637.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67527638.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67527639.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67527640.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67527641.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67527642.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67527643.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68105199.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68105200.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68105201.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68105203.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306318.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69015321.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69015322.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69015325.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69015455.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69016433.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69021314.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309267.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309290.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309359.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309423.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654382.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69662364.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70964105.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70964106.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/0-70964107.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70964108.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70964109.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70964110.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321723.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321724.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321726.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321727.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321728.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72677624.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73002331.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73538908.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73538909.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74289185.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654981.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74791083.html 2024-11-13T14:57:45+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75164835.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75164836.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76174665.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77059377.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77705049.html 2024-11-13T14:57:50+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77705064.html 2024-11-13T14:57:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79197684.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79197706.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-asthma-model-79197710.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79197711.html 2024-11-13T14:57:47+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79197713.html 2024-11-13T14:57:54+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79417113.html 2024-11-13T14:57:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79417114.html 2024-11-13T14:57:50+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79417115.html 2024-11-13T14:57:53+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pk-strategies-of-pdc-79533553.html 2024-11-13T14:57:46+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79533567.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79533569.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79533570.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79533571.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79533572.html 2024-11-13T14:57:49+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79533573.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79533574.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79533575.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79533576.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79533578.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79533579.html 2024-11-13T14:57:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79533580.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79533581.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79533582.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533583.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79533584.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79533585.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79533586.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79533587.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533588.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79533589.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79533590.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79533591.html 2024-11-13T14:57:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mrna-based-therapies-past-79533593.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79533594.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79533595.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79533596.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79533597.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79533598.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79533599.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79533600.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79533601.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533602.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533603.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mrna-based-therapies-present-79533604.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79533605.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79533606.html 2024-11-13T14:57:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79533607.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79533608.html 2024-11-13T14:57:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79533609.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79533610.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/significance-principles-and-requirements-of-79533611.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79535900.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79535901.html 2024-11-13T14:57:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79535902.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79535903.html 2024-08-07T08:44:35+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656501.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81136543.html 2024-11-13T14:57:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/convection-enhanced-delivery-81136544.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-models-of-human-diseases-81136545.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81136546.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81136547.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81136548.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/china-experimental-monkey-industry-81136549.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/human-disease-animal-models-81136550.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81136552.html 2024-11-13T14:57:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81136553.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81136554.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/compartment-pk-model-81136555.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81136907.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395256.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82710092.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82710093.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82710094.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82710095.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82710096.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82710097.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82710099.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82710109.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82710127.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83017881.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83029602.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83030392.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84025131.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84025132.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84025133.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84025134.html 2025-01-20T15:02:39+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84025135.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84025136.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84025137.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84025138.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84025139.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245161125225472.html 2025-02-27T08:15:27+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245161348195328.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17296353446421504.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-models-for-womens-health-17296353568416768.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17296353575199744.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/membranous-nephropathy-model-17296353715151872.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17296353763107840.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17296353826300928.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17296353954735104.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17296354007688192.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17296354034230272.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17296354069029888.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17296354071618560.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17296354106188800.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17296354120573952.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17296354178016256.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17296389706245120.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17296389757051904.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17296389816329216.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17301356910781440.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17383757396501504.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17383757397320704.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17383757409002496.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17383757471867904.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17383757475062784.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17383757506716672.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17383757533471744.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17383757546988544.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17383757576823808.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/intracerebroventricular-icv-injection-17383757631759360.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17383757795468288.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17383757811885056.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17446955047789568.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17446955050738688.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17446955187872768.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17446955191231488.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17446955203650560.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17446955248722944.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17446955317978112.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/key-considerations-for-dosing-volume-17446955370193920.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17446955374404608.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17446955388019712.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17446955867137024.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17446955991852032.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-copd-model-17494154233586688.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17494154254345216.html 2025-08-20T08:06:08+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17494154257703936.html 2025-08-20T08:06:00+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17494154307003392.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17494154411566080.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17494154505839616.html 2025-09-14T05:04:43+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/brain-targeted-drug-delivery-17529381962753024.html 2025-09-14T05:04:51+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529382039561216.html 2025-09-14T05:04:46+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/the-importance-of-administration-volume-17529382055568384.html 2025-09-14T05:04:52+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529382161409024.html 2025-09-14T05:04:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529382179972096.html 2025-09-14T05:04:54+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529382185067520.html 2025-09-14T05:04:47+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529382315582464.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537979712021504.html 2025-09-30T21:27:01+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17552981673419776.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625028285391872.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625028322173952.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625028331447296.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625028458570752.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625028477445120.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625028517635072.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625028519175168.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-renal-biopsy-17625028674954240.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625028684555264.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625029182792704.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625030143632384.html 2025-12-25T16:00:44+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674422398804992.html 2025-12-25T16:00:42+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674422442468352.html 2025-12-25T16:00:50+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674422501975040.html 2025-12-25T16:00:56+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674422522717184.html 2025-12-25T16:00:53+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674422551585792.html 2025-12-25T16:01:05+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674422616138752.html 2025-12-25T16:00:49+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674422627132416.html 2025-12-25T16:00:53+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674422643631104.html 2025-12-25T16:00:58+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674422724666368.html 2026-01-29T19:27:45+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724161810686976.html 2026-01-29T19:27:38+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724161847256064.html 2026-01-29T19:27:48+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724161861116928.html 2026-01-29T19:27:49+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724161871324160.html 2026-01-29T19:27:36+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724161928651776.html 2026-01-29T19:27:42+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724161961436160.html 2026-03-27T18:51:55+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724162059019264.html 2026-01-29T19:27:41+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724162071241728.html 2026-01-29T19:27:45+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724162175984640.html 2026-01-29T19:27:37+08:00 weekly 0.8 https://ee.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724163091784704.html